אינטגרילין 0.75 מגמל

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

EPTIFIBATIDE

Tilgjengelig fra:

MERCK SHARP & DOHME (ISRAEL - 1996) COMPANY LTD, ISRAEL

ATC-kode:

B01AC16

Legemiddelform:

תמיסה לאינפוזיה

Sammensetning:

EPTIFIBATIDE 0.75 MG/ML

Administreringsrute:

תוך-ורידי

Resept typen:

מרשם נדרש

Produsert av:

SCHERING-PLOUGH LABO. N.V , BELGIUM

Terapeutisk gruppe:

EPTIFIBATIDE

Terapeutisk område:

EPTIFIBATIDE

Indikasjoner:

Integrilin is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-Q-wave myocardial infarction. Integrilin is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. Integrilin is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (PTCA) balloon angioplasty, directional atheretomy, transluminal extraction catheter atherectomy, rotational ablation angioplasty, or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death, myorardial infarction, need for urgent intervention). Integrilin is intended for use with aspirin and heparin.

Autorisasjon dato:

2013-10-31